NovoCure Narrows Q3 Loss to $10.44 Million as Revenue Rises 15.7%

NovoCure (NVCR) reported a third-quarter net loss of $10.44 million, or $0.09 per share, a sharp improvement from a loss of $37.27 million, or $0.33 per share, in the same period last year. Revenue for the quarter rose 15.7% to $193.40 million from $167.20 million a year earlier, according to the company's GAAP results. The medical device maker guided full-year revenue to a range of $736 million to $743 million.